Literature DB >> 24408117

Update on membranoproliferative GN.

Naveed Masani1, Kenar D Jhaveri, Steven Fishbane.   

Abstract

Membranoproliferative GN represents a pattern of injury seen on light microscopy. Historically, findings on electron microscopy have been used to further subclassify this pathologic entity. Recent advances in understanding of the underlying pathobiology have led to a proposed classification scheme based on immunofluorescence findings. Dysregulation of the complement system has been shown to be a major risk factor for the development of a membranoproliferative GN pattern of injury on kidney biopsy. Evaluation and treatment of this complex disorder rest on defining the underlying mechanisms.

Mesh:

Substances:

Year:  2014        PMID: 24408117      PMCID: PMC3944764          DOI: 10.2215/CJN.06410613

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  46 in total

1.  Eculizumab for dense deposit disease and C3 glomerulonephritis.

Authors:  Andrew S Bomback; Richard J Smith; Gaetano R Barile; Yuzhou Zhang; Eliot C Heher; Leal Herlitz; M Barry Stokes; Glen S Markowitz; Vivette D D'Agati; Pietro A Canetta; Jai Radhakrishnan; Gerald B Appel
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 8.237

Review 2.  Membranoproliferative glomerulonephritis--a new look at an old entity.

Authors:  Sanjeev Sethi; Fernando C Fervenza
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

3.  Hepatitis C infection and membranoproliferative glomerulonephritis.

Authors:  J M Doutrelepont; M Adler; M Willems; P Durez; S H Yap
Journal:  Lancet       Date:  1993-01-30       Impact factor: 79.321

4.  Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies.

Authors:  J A McCaughan; D M O'Rourke; A E Courtney
Journal:  Am J Transplant       Date:  2012-01-10       Impact factor: 8.086

5.  Causes of alternative pathway dysregulation in dense deposit disease.

Authors:  Yuzhou Zhang; Nicole C Meyer; Kai Wang; Carla Nishimura; Kathy Frees; Michael Jones; Louis M Katz; Sanjeev Sethi; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

6.  Immunohistological and ultrastructural differences between recurrent type I membranoproliferative glomerulonephritis and chronic transplant glomerulopathy.

Authors:  M B Andresdottir; K J Assmann; R A Koene; J F Wetzels
Journal:  Am J Kidney Dis       Date:  1998-10       Impact factor: 8.860

7.  Immunosuppressive treatment of membranoproliferative glomerulonephritis.

Authors:  R Faedda; A Satta; F Tanda; M Pirisi; E Bartoli
Journal:  Nephron       Date:  1994       Impact factor: 2.847

8.  C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.

Authors:  Agustín Tortajada; Hugo Yébenes; Cynthia Abarrategui-Garrido; Jaouad Anter; Jesús M García-Fernández; Rubén Martínez-Barricarte; María Alba-Domínguez; Talat H Malik; Rafael Bedoya; Rocío Cabrera Pérez; Margarita López Trascasa; Matthew C Pickering; Claire L Harris; Pilar Sánchez-Corral; Oscar Llorca; Santiago Rodríguez de Córdoba
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

9.  Eculizumab in a patient with dense-deposit disease.

Authors:  Erica Daina; Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

10.  Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Yuzhou Zhang; Ladan Zand; Nicole C Meyer; Nicolò Borsa; Samih H Nasr; Richard J H Smith
Journal:  Kidney Int       Date:  2012-12-12       Impact factor: 10.612

View more
  14 in total

1.  Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center.

Authors:  Marie Nakano; Kazunori Karasawa; Takahito Moriyama; Keiko Uchida; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2019-03-11       Impact factor: 2.801

2.  Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders.

Authors:  Stefan Michelfelder; Juliana Parsons; Lennard L Bohlender; Sebastian N W Hoernstein; Holger Niederkrüger; Andreas Busch; Nicola Krieghoff; Jonas Koch; Benjamin Fode; Andreas Schaaf; Thomas Frischmuth; Martin Pohl; Peter F Zipfel; Ralf Reski; Eva L Decker; Karsten Häffner
Journal:  J Am Soc Nephrol       Date:  2016-12-08       Impact factor: 10.121

3.  [Basic nephropathology for pathologists-part 1 : Kidney biopsy-inflammation and immune complexes].

Authors:  Maike Büttner-Herold; Ariana Gaspert; Kerstin Amann
Journal:  Pathologe       Date:  2022-03-28       Impact factor: 1.011

4.  Clinical features and pathogenesis of membranoproliferative glomerulonephritis: a nationwide analysis of the Japan renal biopsy registry from 2007 to 2015.

Authors:  Naoki Nakagawa; Naoyuki Hasebe; Motoshi Hattori; Michio Nagata; Hitoshi Yokoyama; Hiroshi Sato; Hitoshi Sugiyama; Akira Shimizu; Yoshitaka Isaka; Shoichi Maruyama; Ichiei Narita
Journal:  Clin Exp Nephrol       Date:  2017-12-06       Impact factor: 2.801

5.  The incidence of possible causes of membranoproliferative glomerulonephritis: a single-center experience.

Authors:  J Pavinic; M Miglinas
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

Review 6.  Complement related kidney diseases: Recurrence after transplantation.

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2016-12-24

Review 7.  Diseases of complement dysregulation-an overview.

Authors:  Edwin K S Wong; David Kavanagh
Journal:  Semin Immunopathol       Date:  2018-01-11       Impact factor: 9.623

8.  Predictive factors of renal involvement in cryoglobulinaemia: a retrospective study of 153 patients.

Authors:  Vladimir Coliche; Marie-Nathalie Sarda; Maurice Laville; Roland Chapurlat; Sylvain Rheims; Pascal Sève; Clémence Théry-Casari; Jean-Christophe Lega; Denis Fouque
Journal:  Clin Kidney J       Date:  2018-11-09

9.  Membranoproliferative glomerulonephritis in a patient with chronic brucellosis.

Authors:  Simella Provatopoulou; Marios Papasotiriou; Evangelos Papachristou; Hariklia Gakiopoulou; Markos Marangos; Dimitrios S Goumenos
Journal:  Kidney Res Clin Pract       Date:  2018-09-30

10.  Primary membranoproliferative glomerulonephritis in Sfax, Tunisia: epidemiologic profile and prognostic factors.

Authors:  Ikram Agrebi; Khawla Kammoun; Najla Dammak; Jamil Hachicha; Tahya Boudawara; Faiçal Jarraya; Mohamed Ben Hmida
Journal:  Pan Afr Med J       Date:  2021-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.